Navigation Links
EPA Focus on Hazardous Pharmaceutical Waste: White Paper Helps Hospitals Avoid Fines
Date:12/5/2007

call 1-800-825-5343.

About EH&E

EH&E (http://www.eheinc.com) has provided an extensive range of environmental and engineering consulting services for 20 years. Our team consists of more than 60 experts with an outstanding record of providing business-focused solutions for issues that affect the built environment. EH&E has a depth of knowledge and credibility unmatched in the industry and our wealth of readily-accessible information has become a powerful resource for our clients. Our new series of EH&E web compliance solutions is just the latest example of our continuing effort to provide this knowledge and information to a wider range of companies.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Kevin Coghlan http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=40931


'/>"/>
SOURCE EH&E
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
2. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
3. This October, the American Physical Therapy Associations National Physical Therapy Month to Focus on Nations Obesity Epidemic
4. ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs
5. Education Key Focus of Michigan Policy Summit
6. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
7. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
8. DuPont Focused on Meeting Global Demands for Greater Safety & Protection
9. New Seminar Series from Activator Methods Teaches Doctors a Unique Approach to Improving Nations Chiropractic Care: Focus on the Patients
10. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
11. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...at the University of Illinois at Chicago, it was f...fter the victim was drugged// and in 5% of the cas...stimated 100,000 sexual assaults are committed in ...hat number could be three times higher if all case...
...red by scientists at UCSF, Celera Genomics and The...reased risk// for early heart attack, or myocardia...P8, normally expresses a protein essential for ear...urs in a coronary blood vessel, it can lead to hea...
...e than 80 million American adults are smokers, obe... poor health and an early death. // Data from a ...estimate the proportion of adults in the United St...roblems. The number of Americans who fall into bo...
...t age related deafness, and hearing loss caused by... red wine, green tea and aspirin. // Explaining t...help slow the development of age-related deafness,...mpounds they contain could help protect the delica...
Other Medicine News:Health News:UIC Study Throws Light On Sexual Assaults 2Health News:Gene Variants Linked to Early Heart Attack Discovered 2Health News:Gene Variants Linked to Early Heart Attack Discovered 3Health News:Gene Variants Linked to Early Heart Attack Discovered 4Health News:Red Wine May Reduce The Risk Of Age Related Deafness 2
(Date:9/5/2008)...Calif., Sept. 5 /- SARcode,...lecule LFA-1 inhibitors,to treat inflammatory dise...NSS) today announced SARcode,s initiation of a Pha...uct candidate for T-cell mediated ophthalmic,disea...reement providing,SARcode with an exclusive licens...
(Date:9/5/2008)...microRNAs Extracted From a Simple Blood Draw Have,...rkers for a Wide Range of ..., Rosetta Genomics is Currently Developing ... REHOVOT, Israel and JERSEY CITY, New Jersey, Sept..., Ltd. (NASDQ: ROSG), a leader in,the development ...
(Date:9/4/2008)... designation for the treatment of Acute Myeloid ... N.J., Sept. 4 /- Celator Pharmaceuti...inistration (FDA) has granted orphan,drug designat...Injection,for the treatment of Acute Myeloid Leuke...duct two randomized Phase 2,studies with CPX-351. ...
(Date:9/4/2008)...aqMan(R) real-time PCR testing for the diagnostic ... Calif., Sept. 4 /- The U.S. Food & D...BAS(R) TaqMan(R) HBV Test,the first assay for qua...S.,The test uses Roche,s real-time PCR technology ... a patient,s blood. Doctors may use viral load,tes...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease 1582 1Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease 1582 2Cancer research giants collaborate to present the CTRC AACR San Antonio Breast Cancer Symposium 8198 1Cancer research giants collaborate to present the CTRC AACR San Antonio Breast Cancer Symposium 8198 2Cancer research giants collaborate to present the CTRC AACR San Antonio Breast Cancer Symposium 8198 3John Alexandrov Reveals the Secret to Financial Success Via Launch of The Power of Deliberate Creation Audio CDs 8194 1John Alexandrov Reveals the Secret to Financial Success Via Launch of The Power of Deliberate Creation Audio CDs 8194 2John Alexandrov Reveals the Secret to Financial Success Via Launch of The Power of Deliberate Creation Audio CDs 8194 3SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth 8189 1
...ND OAKS, Calif. & COLLEGEVILLE, Pa.--(BUSINESS...th Pharmaceuticals, a,division of Wyeth (NYSE:WYE)...ata that showed that the safety profile of Enbrel(...in patients with,moderate-to-severe juvenile rheum...ars of therapy. JRA is a chronic autoimmune,diseas...
...TON, Mass.--(BUSINESS WIRE)--Jun 13, 2007 - EPIX,P...d that data from,its Phase 3 trial of PRX-00023, a... a poster presentation at the 47th Annual New,Clin...Raton,Florida. The meeting is sponsored by the Na...ty of Clinical Psychopharmacology., The presentati...
Other Medicine Technology:Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 2Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 3Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 4Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 5Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 6Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 7Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 8EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4
Excellent for manipulation of the intraocular lens in the capsular bag. The angled and curved shaft allows the instrument to reach across the implant and catch the optic/ haptic junction to facilitat
Angled shaft with 1.5 mm tip designed to efficiently perform the "Stop and Chop" technique. Round knurled handle. Most popular size or model.
This double ended instrument was designed for delineating and lifting the corneal flap of previously performed lamellar refractive surgery cases.
Used when dislocating the lens. Great for chopping during phacoemulsification. Helpful in ushering the IOL out of eye. Useful to reduce possibility of iris tuck with anterior chamber IOL placement.
Medicine Products: